Analyzing Astrana Health (NASDAQ:ASTH) & Jade Art Group (OTCMKTS:JADA)

Jade Art Group (OTCMKTS:JADA) and Astrana Health (NASDAQ:ASTH) are both small-cap consumer discretionary companies, but which is the better investment? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, institutional ownership, dividends and risk.

Analyst Ratings

This is a summary of current ratings and target prices for Jade Art Group and Astrana Health, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jade Art Group	0	0	0	0	0.00
Astrana Health	0	2	6	1	2.89

Astrana Health has a consensus price target of $56.17, indicating a potential upside of 79.10%. Given Astrana Health’s stronger consensus rating and higher possible upside, analysts clearly believe Astrana Health is more favorable than Jade Art Group.

Profitability

This table compares Jade Art Group and Astrana Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Jade Art Group	N/A	N/A	N/A
Astrana Health	3.63%	9.37%	5.32%

Volatility and Risk

Jade Art Group has a beta of 2.26, suggesting that its share price is 126% more volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.3, suggesting that its share price is 30% more volatile than the S&P 500.

Valuation & Earnings

This table compares Jade Art Group and Astrana Health”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jade Art Group	N/A	N/A	N/A	N/A	N/A
Astrana Health	$2.03 billion	0.77	$60.72 million	$0.89	35.24

Astrana Health has higher revenue and earnings than Jade Art Group.

Institutional & Insider Ownership

52.8% of Astrana Health shares are held by institutional investors. 8.5% of Astrana Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Summary

Astrana Health beats Jade Art Group on 10 of the 11 factors compared between the two stocks.

About Jade Art Group

Jade Art Group Inc., through its subsidiary, JiangXi SheTai Jade Industrial Company Limited, engages in the sale and distribution of raw jade in China. It also involves in jade processing, carving, and polishing activities. The company's products are used as decorative construction material in commercial and residential markets, and high-end jewelry. Jade Art Group Inc. is based in Yingtan, China.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.